Regulatory Mechanism of Biosynthesis and Cellular Action of Renal Vasoactive Hormones.

肾血管活性激素生物合成和细胞作用的调节机制。

基本信息

  • 批准号:
    63480221
  • 负责人:
  • 金额:
    $ 3.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1990
  • 项目状态:
    已结题

项目摘要

1. Effect of Atrial Natriuretic Peptide on Cytosolic Free CalciumWe developed the method of measuring intracellular calcium using fluorescent calcium indicators (fura-2 & indol). Atrial natriuretic peptide (ANP) decreased either the resting level of intracellular calcium or sustained increases in cytosolic calcium induced by vasoconstrictive hormones, angiotensin II and vasopressin. ANP also decreased an increase in intracellular calcium evoked by high potassium depolarization. On the other hand, the initial increases in cytosolic free calcium induced by the hormones were not inhibited by ANP. Calcium antagonists, nicardipine and nifedipine, inhibited the increase in cytosolic free calcium induced by high potassium depolarization, whereas they did not affect increases in intracellular calcium brought about by angiotensin II and vasopressin. The results indicate that ANP can decrease intracellular calcium level and it is suggested that ANP stimulates a calcium-extrusion active transport … More in vascular smooth muscle cells.2. Intracellular Compartmetalization of Fura-2 Demonstrated by Laser-Excitation Fluorescence MicroscopyWhen we examined cytosolic free calcium level in individual cell using laser-excitation fluorescence microscopy, we observed inhomogenous distribution of fura-2 dye. Subcellurar fluorescence of fura-2 dye appeared spotty or filamentous and resembled in shapes the intracellular organelles. Using either an analysis by high performance liquid chromatography or fluorescence spectra analysis, we examined fura-2/AM metabolism in smooth muscle cells. It has been shown that no other than fura-2 was found in the soluble fraction of the cell lysates, whereas membrane fraction contains fura2/AM or its unidentified lipophilic metabilites, In conclusion, we should take into account these problems ( intracellular compartmentalization of fura-2 or fura-2 metabolism ) in measuring intracellular calcium level in individual vascular smooth muscle cell.3. Separation of Inositol phosphates by High Performance Liqu Chromatography : Effect of Bradykinin.We observed bradykinin-induced increase in cytosolic free vascular smooth muscle cells. In order to examine the mechanis we examined the effect of bradykinin on phosphoinositide hydrol sis. We newly developed the method of separation of inosit phosphates using high pressure liquid chromatography. By t method, we separated isomers of inositol monophosphate, isome of inositol bisphosphate, inositol (1,3,4)trisphosphate a inositol ( 1, 4, 5 ) trisphosphate, inositol (1, 3, 4, 5 ) tetrakisphosphate, inositol pentakisphosphate and inosit hexakisphosphate, Bradykinin stimulated rapid formation inositol (1, 4, 5) trisphosphate, followed by formation of inosit tetrakisphosphate and inositol (1, 3, 4) trisphosphate. It idicat that bradykinin induces an increase in cytosolic free calci mediated by inositol (1, 4, 5) trisphosphate4. Relationship between Bradykinin-Induced Increase in Calci and Prostaglandin Synthesis.Bradykinin stimulates an increase in cytosolic free calcium vascular smooth muscle cells. Bradykinin also stimulate prostacyclin synthesis in the cells. To clarify the ti courserelationship between prostacyclin synthesis and calc increase induced by bradykinin, we developed a perfused monolay system which enables to monitor simulataneously the level cytosolic calcium ( using fura-2 method ) and proxtacycl production in the perfusion solution. The result clearly show that bradykinin simultaneously induces an increase in cytosol free calcium and prostacyclin synthesis. It is suggested the calcium is supplied by bradykinin (mediated by phoshpholipase pathway) to phospholipase A which is ready to be activated by t bradykinin-receptor complex, resulting in prostacycin synthesi Less
1. 心房钠尿肽对细胞质游离钙的影响我们开发了使用荧光钙指示剂(fura-2 和吲哚)测量细胞内钙的方法。心房钠尿肽(ANP)可降低细胞内钙的静息水平或使细胞质钙持续增加。由血管收缩激素、血管紧张素 II 和加压素诱导的 ANP 也能降低高钾引起的细胞内钙的增加。另一方面,由激素诱导的胞质游离钙的初始增加不受ANP钙拮抗剂尼卡地平和硝苯地平的抑制,但它们不影响高钾去极化诱导的胞质游离钙的增加。血管紧张素 II 和加压素引起的细胞内钙含量。结果表明,ANP 可以降低细胞内钙水平,表明 ANP 会刺激激光激发荧光显微镜证实 Fura-2 的细胞内钙挤压主动转运…更多当我们使用激光激发荧光显微镜检查单个细胞中的胞质游离钙水平时,我们观察到 fura 的不均匀分布-2 染料。fura-2 染料的亚细胞荧光呈斑点状或丝状,并且与细胞内细胞器的形状相似。通过高效液相色谱或荧光光谱分析,我们检查了平滑肌细胞中的fura-2/AM代谢,结果表明,在细胞裂解物的可溶部分中没有发现除fura-2以外的物质,而膜部分则含有fura2。 /AM或其未鉴定的亲脂性代谢物,总之,在测量个体血管平滑肌细胞内钙水平时,我们应该考虑这些问题(fura-2或fura-2代谢的细胞内区室化) 3.通过高效液相色谱法分离肌醇磷酸:缓激肽的作用。为了研究缓激肽对磷酸肌醇水解的作用,我们观察了缓激肽诱导的细胞质游离血管平滑肌细胞的增加。开发了高压液相色谱法分离肌醇磷酸酯的方法,我们分离了肌醇的异构体。单磷酸酯,肌醇二磷酸酯异构体,肌醇(1,3,4)三磷酸酯,肌醇(1,4,5)三磷酸酯,肌醇(1,3,4,5)四磷酸酯,肌醇五磷酸酯和肌醇六磷酸酯,缓激肽刺激快速形成肌醇(1,4,5)三磷酸,随后形成肌醇四磷酸和肌醇 (1, 3, 4) 三磷酸 表明缓激肽可诱导肌醇 (1, 4, 5) 三磷酸介导的胞质游离钙增加4。缓激肽诱导的钙增加与前列腺素合成之间的关系。血管平滑肌细胞胞质游离钙的增加也刺激前列环素的合成。为了阐明前列环素合成与缓激肽诱导的钙增加之间的关系,我们开发了一种灌注单层系统,该系统能够同时监测灌注溶液中的胞质钙水平(使用 fura-2 方法)和前列环素产生。结果清楚地表明,缓激肽同时诱导胞质游离钙和前列环素合成的增加,这表明钙是由缓激肽提供的(由缓激肽介导)。磷脂酶途径)转化为磷脂酶 A,磷脂酶 A 已准备好被 t 缓激肽受体复合物激活,从而导致前列环素合成 Less

项目成果

期刊论文数量(84)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.KUDO,K.ABE,S.CHIBA et al.: "ROLE OF THROMBOXANE A_2 IN THE HYPERTENSIVE EFFECT OF CAPTOPRIL IN ESSENTIAL HYPEPTENSION" HYPERTENSION. 11. 147-152 (1988)
K.KUDO、K.ABE、S.CHIBA 等人:“THROMBOXANE A_2 在卡托普利对原发性高血压的高血压作用中的作用”高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Takeuchi,K.Yoshinaga H.Inaba et al.: "INTRACELLULAR COMPARTMENTALIZATION OF fura-2 DYE DEMONSTRATED BY LASER EXCITATION FLUORESCECE MICROSCOPY:A PROBLEM IN MEASURING CYTOSOLIC FREE CALCIUM CONCENTRATION USING fura-2 FLUORESCENE IN VASCULAR SMOOTH MUSCLE
K.Takeuchi、K.Yoshinaga H.Inaba 等人:“通过激光激发荧光显微镜演示的 fura-2 染料的细胞内区室化:使用 fura-2 荧光在血管平滑肌中测量细胞溶质游离钙浓度的问题
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.SATO,K.ABE,M.YASUJIMA et al.: "INHIBITORY EFFECT OF CICLETANINE ON VASCULAR SMOOTH MUSCLE CELL PROLIFERATION" ARCH.MAL.COEUR.82. 63-66 (1989)
M.SATO、K.ABE、M.YASUJIMA 等人:“环己宁对血管平滑肌细胞增殖的抑制作用” ARCH.MAL.COEUR.82。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.TAKEUCH,K.ABE,K.MAEYAMA et al: "DIFFERENCE BETWEEN THE EFFECTS OF ATRIAL NATRIURETIC PEPTIDE AND CALCIUM ANTAGONIST ON CYTOSOLIC FREE CALCIUMIN CULTURED VASCULAR SMOOTH MUSCLE CELLS" JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 13. 13-16 (1989)
K.TAKEUCH、K.ABE、K.MAEYAMA 等人:“心房钠尿肽和钙拮抗剂对胞质游离钙培养的血管平滑肌细胞的影响之间的差异”心血管药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ABE Keishi其他文献

ABE Keishi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ABE Keishi', 18)}}的其他基金

Cellular and molecular anaylsis of glomerular and tubular functions in hypertension
高血压肾小球和肾小管功能的细胞和分子分析
  • 批准号:
    07457237
  • 财政年份:
    1995
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Intracellular signal transduction and functional regulation along the nephron segmnents.
沿肾单位段的细胞内信号转导和功能调节。
  • 批准号:
    03454246
  • 财政年份:
    1991
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Standardization and problems to measure prostanoids in the biological fluid.
测量生物体液中前列腺素的标准化和问题。
  • 批准号:
    03557039
  • 财政年份:
    1991
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似国自然基金

害虫神经细胞内钙离子检测新方法及蜘蛛毒素杀虫评价研究
  • 批准号:
    22304082
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
手法调控瞬时受体电位敏化介导“椎骨错缝”CLBP大鼠细胞内钙稳态的效应机制研究
  • 批准号:
    82305426
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGLT2i通过CaMKⅡ的O-GlcNAc糖基化调控细胞内钙在2型糖尿病相关房颤中的作用及机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ANXA5-NCX1调节细胞内钙稳态影响脓毒症心肌收缩力的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

ShEEP Request for EasyRatioPro Cell Imaging System
ShEEP 请求 EasyRatioPro 细胞成像系统
  • 批准号:
    9211812
  • 财政年份:
    2016
  • 资助金额:
    $ 3.9万
  • 项目类别:
Pain-Associated Neuronal Hyperexcitability and Intracellular Calcium Signaling
疼痛相关的神经元过度兴奋和细胞内钙信号传导
  • 批准号:
    8819171
  • 财政年份:
    2015
  • 资助金额:
    $ 3.9万
  • 项目类别:
Pain-Associated Neuronal Hyperexcitability and Intracellular Calcium Signaling
疼痛相关的神经元过度兴奋和细胞内钙信号传导
  • 批准号:
    8989479
  • 财政年份:
    2015
  • 资助金额:
    $ 3.9万
  • 项目类别:
Cytokines dysregulate intracellular calcium and cause beta-cell death in diabetes
细胞因子失调细胞内钙并导致糖尿病中的β细胞死亡
  • 批准号:
    7691970
  • 财政年份:
    2009
  • 资助金额:
    $ 3.9万
  • 项目类别:
Cytokines dysregulate intracellular calcium and cause beta-cell death in diabetes
细胞因子失调细胞内钙并导致糖尿病中的β细胞死亡
  • 批准号:
    7916764
  • 财政年份:
    2009
  • 资助金额:
    $ 3.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了